Physician profile
Robert J Dimeff
NPI 1003870718
$105,803.79
in general payments reported to CMS, 2019-2025
10 companies · $4,407 in 2025
The $4,407 reported for 2025 was more than what 97% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75K · 2020: $23K · 2021: $2,807 · 2022: $713 · 2023: $124 · 2024: $60.49 · 2025: $4,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,250 · Food and Beverage: $341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,250.00 |
| Food and Beverage | $341.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $44,325.76 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $34,496.84 | 2019-2025 | Euflexxa |
| Sanofi-Aventis U.S. LLC | $15,954.08 | 2019-2025 | |
| Orthogenrx INC. | $10,000.00 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $712.98 | 2022-2025 | Zilretta, Iovera |
| Stryker Corporation | $141.57 | 2019 | |
| Pylant Medical | $127.22 | 2019 | |
| Depuy Synthes Sales INC. | $28.04 | 2023-2025 | Monovisc, Orthovisc |
| Ermi LLC | $17.30 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dimeff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.